Chymase level is a predictive biomarker of dengue hemorrhagic fever in pediatric and adult patients

• Main Authors: Rathore, Abhay P. S., Pike, Brian L., Warkentien, Tyler E., Farouk, Farouk S., Gubler, Duane J., St. John, Ashley L., Ooi, Eng Eong, Tissera, Hasitha, Leong, Wei Yee, Syenina, Ayesa, Wilder-Smith, Annelies
• 其他作者: Lee Kong Chian School of Medicine (LKCMedicine)
• 格式: Article
• 語言: English
• 出版: 2019
• 主題: Science::Medicine; Dengue Fever; Dengue Virus
• 在線閱讀: https://hdl.handle.net/10356/106399; http://hdl.handle.net/10220/49609

Background: Most patients with dengue experience mild disease, dengue fever (DF), while few develop the life-threatening diseases dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). No laboratory tests predict DHF or DSS. We evaluated whether the serum chymase level can predict DHF or DSS...